The octapeptide Asp-Gly-Gly-Ser-Glu-Ser-Glu-Gly and the hexadecapeptide Asp-Gly-Gly-Ser-Glu-Ser-Glu-Gly-Lys-Asn-Gly-Ser-Gln-Met-Arg-Leu, part of a tuberculin-active intracellular mycobacterial protein, were synthesized. The synthetic peptides were shown to possess tuberculin activity by their ability to elicit a delayed-type allergic reaction in skin tests on Mycobacterium tuberculosissensitized guinea pigs. Purified protein derivative, the complex mixture of proteins of unknown composition which are excreted into the culture medium by M. tuberculosis and which is in wide use as a tuberculin-active preparation, was shown to cross-react weakly in the radioimmunoassays with the synthetic octapeptide when the 125I-labeled octapeptide and an anti-octapeptide antiserum were used.
The composition of purified protein derivative (PPD; 10), the widely used tuberculin-active preparation obtained from the products excreted by Mycobacterium tuberculosis, is not known, nor has the exact nature been found of the antigenic determinants responsible for the delayed-type allergic reaction when PPD or other mycobacterial extracts are administered intracutaneously to humans or other animals sensitized with tubercle bacilli.
In an attempt to further the present knowledge of this question, I reported previously (9) the synthesis and biological assays of a heptapeptide (70 to 76; Fig. 1 ), part of an intracellular tuberculin-active protein isolated by Kuwabara from human tubercle bacilli (5, 6) . The synthetic heptapeptide (70 to 76; Fig. 1 ) was found to be devoid of any residual tuberculin activity, in contradiction to reported results (6) , but by a radioimmunoassay procedure, its presence in PPD has been established (9) .
The present study describes the synthesis of the octapeptide (61 to 68; Fig. 1 ) and of the hexadecapeptide (61 to 76; Fig. 1) , part of the tuberculin-active protein isolated by Kuwabara (6) . It 3-(4-hydroxyphenyl) propionic acid N-succinimidyl ester, was purchased from Amersham Ltd., Amersham, England; Sephadex G-15 and G-25 were purchased from Pharmacia Fine Chemicals, Inc., Piscataway, N.J.; and Cellex-D, as well as Bio-Gel P-2 (200 to 400 mesh), was from Bio-Rad Laboratories, Richmond, Calif. All other reagents and L-amino acid derivatives were purchased or generously given as described previously (9) . Experimental procedures for the synthesis of the octapeptide Asp-Gly-Gly-Ser-Glu-Ser-Glu-Gly. (i) Silica gel thin-layer chromatography. Silica gel thin-layer chromatography was run in: A, n-butanol-acetic acidwater (3:1:1); B, chloroform-methanol (20:1); and C, chloroform-methanol (2:1). Free amino functions were revealed with ninhydrin, and N-protected peptides were revealed by the chlorine-4,4'-tetramethyldiamino-diphenylmethane procedure (11) .
(ii) Z-Glu(OBut)-Gly-OMe (I). A solution of Nt-Zglutamic acid -y-t-butyl ester (3.37 g, 10 mmol) and Nmethylmorpholine (1.1 ml, 10 mmol) in dry tetrahydrofuran (50 ml) was cooled to -15°C, and ethyl chloroformate (0.96 ml, 10 was dissolved in methanol (80 ml) and submitted to catalytic hydrogenolysis in the presence of 10% Pd-C and acetic acid (1 ml). At the end of the reaction, the solution was titrated to pH 4.5 with 1 N hydrogen chloride in methanol, filtered, and evaporated to dryness. The 3-t-butyl-L-seryl-^y-t-butyl-L-glutamyl-glycine methyl ester hydrochloride (4.36 g, 9.6 mmol) was obtained as a solid by trituration of the residual oil in ether-n-hexane (1:1) and was coupled to N-Z-glutamic acid -y-t-butyl ester (3.24 g, 9.6 mmol) by the procedure described for the preparation of dipeptide (I). After the usual work-up, the product crystallized out from ethyl acetate upon the addition of an equal volume of n-hexane. mmol) was dissolved in methanol (50 ml) and submitted to catalytic hydrogenolysis in the presence of 10% Pd-C and acetic acid (0.7 ml). At the end of the reaction, the solution was titrated to pH 4.5 with 1 N hydrogen chloride in methanol, filtered, and evaporat- 
The fully protected pentapeptide (IV) (4.40 g, 5 mmol) was dissolved in dioxane (160 ml) and water (16 ml), and the methyl ester was saponified at pH 11.5 by the addition of 1 N sodium hydroxide. At the end of the reaction, the product precipitated out upon the addition of 2 M potassium hydrogen sulfate to pH 2.5 and upon the dilution of the reaction mixture with water. After being washed with water and dried, the product was recrystallized from ethyl acetate. The yield was 3.68 g (85%) (mp 210 (vii) II-Ser(But)-Glu(OBu')-Ser(But)-Glu(OBut)-Gly-OH hydrochloride (VI). The partially protected pentapeptide (V) (4.33 g, 5 mmol) was dissolved in methanol (250 ml) and water (5 ml) and was submitted to catalytic hydrogenolysis in the presence of 10% Pd-C and 1 N hydrochloric acid (5 ml, 5 mmol). The filtered solution was evaporated to a small volume. The repeated addition of ethanol and evaporation gave a gel, which on trituration in n-hexane yielded the product as an amorphous solid. Pentapeptide hydrochloride (VI) moved as a single spot on chromatograms (RfA, 0.54) and was used without further purification. The yield was 3.69 g (96%).
(viii) BOC-Asp(OBu')-G1y-Gly-OBzl (VII). Nt-t-butyloxycarbonyl-glycyl-glycine benzyl ester (3) (3.22 g,VOL. 40, 1983 dicyclohexylamine (2.0 ml, 10 mmol), the Nt-BOC-I3-t-butyl-L-aspartyl-glycyl-glycine dicyclohexylammonium salt crystallized out and was washed with ether. The yield was 5.26 g (90%) (mp 112 to 115°C [uncorrected]). The product was suspended in ethyl acetate and washed with 0.2 M potassium hydrogen sulfate and water. The organic solution was dried over magnesium sulfate and evaporated to dryness. The residual oil was redissolved in ether (20 ml), and n-hexane was added dropwise to the solution to precipitate the Nt-BOC-0-t-butyl-L-aspartyl-glycyl-glycine as a fine powder. The yield was 3.12 g (77%) (mp 78°C after sintering (
Tripeptide (VIII) (807 mg, 2 mmol) and N-hydroxysuccinimide (230 mg, 2 mmol) were dissolved in dioxane (10 ml) and ethyl acetate (2 ml). The solution was cooled to 0°C, and dicyclohexylcarbodiimide (412 mg, 2 mmol) in ethyl acetate (2 ml) was added. The reaction mixture was left to stir at 0°C for 30 min and then at 4°C overnight. After dilution with ethyl acetate (50 ml), the reaction mixture was left in the refrigerator for 2 h, the crystallized dicyclohexyl urea was filtered off, and the solution was evaporated to dryness. Thus prepared, 1-succinimidyl ester of tripeptide (VIII), obtained as an oil (1.00 g, 2 mmol) was dissolved in dimethylformamide (20 ml) and added to a solution of pentapeptide hydrochloride (VI) (1.24 g, 1.62 mmol) in dimethylformamide (35 ml) containing triethylamine (0.90 ml, 6.5 mmol). The reaction mixture was stirred for 24 h at room temperature, the pH was adjusted to 3 with 0.2 M potassium hydrogen sulfate, and the product was precipitated by the addition of water, filtered, and washed with 0.05 M potassium hydrogen sulfate and water. The dry, crude protected octapeptide was extracted with hot acetone, and after an insoluble contaminant was centrifuged off, the clear solution was evaporated to a small volume. Upon the addition of nhexane, the partially protected octapeptide (IX) precipitated out. The yield was 1.48 g (82%) ( (xi) H-Asp-Gly-Gly-Ser-Glu-Ser-Glu-Gly-OH (X). The partially protected octapeptide (IX) (559 mg, 0.5 mmol) was dissolved in TFAOH (20 ml) at 20°C and left to stand for 45 min. After evaporation to dryness at 20°C under reduced pressure, the trifluoroacetate of the free octapeptide (X) was obtained as a solid by trituration of the residual oil in ether. The yield was 421 mg (99%). The product was dissolved in 25 mM sodium chloride (1.4 ml), 1 N sodium hydroxide (approximately 250 ,ul) was added to bring the pH of the solution to 3.5, and the product was chromatographed on a column of Bio-Gel P-2 (1.6 by 84 cm) prepared in 25 mM sodium chloride. The chromatographically pure material which emerged at a Ve of 75 to 85 ml was lyophilized, redissolved in water (1 ml), and desalted on Bio-Gel P-2. The yield of the lyophilized pure octapeptide (X) was 232 mg (63%) (RfA, 0.03). Paper electrophoresis by the procedure described by Offord (7) gave a ninhydrin-positive spot with the expected electrophoretic mobility (m = 0.82). The amino acid analysis of an acid hydrolysate of the product gave Asp, 0.97; Ser, 1.74; Glu, 2.03; Gly, 3.00.
Experimental procedures for the synthesis of the hexadecapeptide Asp-Gly-Gly-Ser-Glu-Ser-Glu-GlyLys-Asn-Gly-Ser-Gln-Met-Arg-Leu. (9) (2.30 g, 2 mmol) was dissolved in TFAOH (60 ml) at 20°C in the presence of thioanisole (11.7 ml, 100 mmol) and left to stand for 1 h. After evaporation to dryness at 20°C under reduced pressure, the N-deprotected heptapeptide trifluoroacetate (RfA, 0.33) was obtained as a solid (2.28 g, 98%) by a thorough trituration of the residual oil in ether and coupled at 20°C for 24 h with NV-BOC-NE-Z-lysine 1-succinimidyl ester (4) (1.24 g, 2.6 mmol) in dimethylformamide (20 ml) in the presence of N-methylmorpholine (0.29 ml, 2.6 mmol). The crude octapeptide (XI), which precipitated out of the reaction mixture upon the addition of water, was dried, washed with ether, and digested with hot ethanol. On cooling, the pure product was filtered and washed with absolute ethanol. The yield was 2.12 g (75%) (mp 218 to 220°C [uncorrected]; RfA, 0.60). . After 2 h at 0°C, the reaction mixture was left to stir at room temperature for 5 days. Upon the addition of water to the thick gel formed, the crude hexadecapeptide (RfA, 0.53), contaminated with dicyclohexyl urea, precipitated out. The yield was 1.21 g. Because of unfavorable solubility properties, the crude protected hexadecapeptide (XII) was used without further purification.
(iii) H-Asp-Gly-Gly-Ser-Glu-Ser-Glu-Gly-Lys-AsnGly-Ser-Gln-Met-Arg-Leu-OH (XIII). The crude protected hexadecapeptide (XII) (603 mg, 0.25 mmol) was treated with thioanisole (1.47 ml, 12.5 mmol), and 1 M boron tris(trifluoroacetate) in TFAOH (8) (25 ml, 25 mmol) was added at 0°C. After 5 min at 0°C, the reaction mixture was stirred at room temperature for 1.5 h and evaporated to dryness at 25°C under reduced pressure. Water (100 ml) was added to the residual oil, the aqueous solution was twice extracted with ethyl acetate, and after titration to pH 4.7 with 1 M sodium hydroxide, the solution was again extracted with ethyl acetate and evaporated to a small volume (10 ml) by azeotropic distillation under reduced pressure at 35°C in the presence of ethanol. Part of the boric acid that was formed as a by-product, crystallized out, was filtered off, and washed with water. The combined aqueous filtrates (16 ml) were desalted on a column of on September 7, 2017 by guest http://iai.asm.org/ Downloaded from SAVRDA Sephadex G-15, and the salt-free, peptide-containing fractions were lyophilized. The yield was 240 mg (0.145 mmol). Paper electrophoresis at pH 6.5 (7) showed this preparation to be a complex mixture of products, among which the required hexadecapeptide (XIII) could be identified by its Sakaguchi-positive reaction and by its complete disappearance after digestion with trypsin. The crude product (240 mg) was dissolved in 0.01 M phosphate buffer (1.5 ml; pH 7.0) and chromatographed on a column of Sephadex G-25 (fine; 1.6 by 85 cm) in the same solvent. The fractions enriched in hexadecapeptide (XIII) (Ve, 92 to 104 ml) were lyophilized, dissolved in water (1.5 ml), and desalted on Sephadex G-15. After lyophilization of the peptide-containing, salt-free fractions, the yield of the product was 116 mg (0.07 mmol). This material was chromatographed in two portions of 58 mg dissolved in 1 mM phosphate buffer (2.5 ml; pH 6.6) on a column of Cellex-D (2.6 by 43 cm) prepared in the same solvent. After the product on the column was washed with 1 mM phosphate buffer (400 ml), a linear sodium chloride gradient was applied (830 ml of 1 mM phosphate buffer [pH 6.6] against 830 ml of 0.4 M sodium chloride-1 mM phosphate buffer [pH 6.6]). The fractions containing the hexadecapeptide (Ve, 235 to 309 ml) were lyophilized, desalted on Sephadex G-15, and again lyophilized. The total yield of the pure hexadecapeptide (XIII) was 27 mg (16 ,umol, 6.5%). Paper electrophoresis at pH 6.5 (7) gave a single ninhydrinand Sakaguchi-positive spot with the expected electrophoretic mobility (m = 0.16). The amino acid analysis of an acid hydrolysate of the product gave Arg, 1.00; Asp, 1.96; Glu, 3.03; Gly, 3.92; Leu, 1.01; Lys, 1.02; Met, 0.88; Ser, 2.51. Paper electrophoresis at pH 6.5 of a tryptic digest of the product gave three spots identified as Leu (m = 0.00), Asn-Gly-Ser-Gln-MetArg (m = 0.34, Sakaguchi positive), Asp-Gly-Gly-SerGlu-Ser-Glu-Gly-Lys (m = 0.51).
Preparation of octapeptide (X) conjugate. A bovine serum albumin (BSA)-octapeptide conjugate was prepared from BSA (25 mg) and octapeptide (X) (10 mg) by reaction with glutaraldehyde under the conditions described previously (9) . The amount of octapeptide coupled to BSA was 17 mol/mol of BSA.
Immunization procedure. Rabbits were immunized by multisite subcutaneous injections of 2 mg of the BSA-octapeptide conjugate in the presence of muramyl dipeptide (2) and Freund incomplete adjuvant as described previously (9) . Enzymatic digestions. Solutions (1%) of octapeptide (X), hexadecapeptide (XIII), or PPD (PPD-neutre Pasteur) were digested with trypsin, and the digests were passed on Sepharose-bound soybean trypsin inhibitor as described previously (9) . The resulting solutions were further treated with carboxypeptidase B, with an exopeptidase-to-substrate weight ratio of 1:100, at 25°C for 2 h and then heated for 5 min at 100°C. These stock solutions (800 ,ug of hydrolyzed substrate per 100 ,ul) were diluted before use with 0.05 M Tris buffer (pH 7.4), containing 0.15 M sodium chloride, 0.1% sodium azide, and 0.5% BSA.
M. tuberculosis Aoyama/B and M. bovis BCGPasteur extracts were likewise digested with trypsin and carboxypeptidase B, except that the concentrations of the substrates (protein) were 0.04 and 0.6%, respectively.
Radioimmunoassay procedure. The radioimmunoassays were performed as described previously (9) Peptide synthesis. The octapeptide (X) AspGly-Gly-Ser-Glu-Ser-Glu-Gly and the hexadecapeptide (XIII) Asp-Gly-Gly-Ser-Glu-Ser-GluGly-Lys-Asn-Gly-Ser-Gln-Met-Arg-Leu were synthesized as described above by standard procedures of classical solution peptide synthesis and, in particular, under conditions known not to give rise to racemization.
Tuberculin activity of octapeptide (X) and of hexadecapeptide (XIII). When a 200-[.g dose of octapeptide (X) in 100 pAl of phosphate-buffered saline was administered intradermally to guinea pigs sensitized with BEG, a weak skin reaction (4 mm) of low color intensity could be observed after 24 h. The administration of a 200-,ug dose of hexadecapeptide (XIII) to BCG-sensitized guinea pigs elicited after 24 h a slightly stronger skin reaction (8 mm) but still of low color intensity. In BCG-sensitized guinea pigs, the administration of antigens (X) and (XIII) provoked little or no induration, whereas the injection of 10 U (approximately 0.1 pug) of PPD to these animals elicited, on the average, an erythematous area of 14 mm in diameter and an induration of 16 mm. However, the administration of a 200-,ug dose of hexadecapeptide (XIII) to M. tuberculosis Peurois-sensitized guinea pigs elicited after 24 h a normal tuberculin-type skin reaction with, on the average, an erythematous area of 11 mm in diameter and an induration of 12 mm. In these animals, 10 U of PPD provoked an erythema of 14 mm and an induration of 16 mm ( Fig. 2A) . The histological examination of biopsies of the skin showed that the reactions elicited by PPD (Fig. 2B ) and by hexadecapeptide (XIII) (Fig. 2C) were similar, except that the reaction caused by the synthetic peptide contained a higher percentage of polymorphonuclear cells.
Radioimmunoassays. An antiserum capable of binding 50% of a 10,000-cpm dose of the 1251_ labeled octapeptide (X) at a 1:2,000 dilution and showing a good affinity for this antigen was selected for the radioimmunoassays. In Fig. 3 are summarized the amounts of unlabeled octapeptide (X) and undigested or trypsin-and carboxypeptidase B-digested hexadecapeptide (XIII), PPD, and Aoyama/B or BCG extracts required to displace half of the label in the radioimmunoassays. VOL. 40, 1983 FIG. 3. Amounts of cold antigens added to radioimmunoassays to achieve 50% inhibition of binding of "251-labeled octapeptide (X) to its antiserum. The numbering of the amino acid residues in the synthetic peptide sequences is as in Fig. 1 Only 250 pg of the cold synthetic octapeptide (X) were required to displace half of the label in the radioimmunoassays, using antibodies raised against this peptide (conjugated through its Nterminal a-amine to BSA) and the NO-'25I-labeled octapeptide (X). For our purposes, however, the advantage of this good sensitivity of the assays was, to some extent, diminished by the great specificity of the antibodies, which were strongly directed to the C-terminal end of octapeptide (X). Thus, when the C-terminal glycine residue of octapeptide (X) was implicated in a peptide linkage, as in the case of hexadecapeptide (XIII), the observed level of recognition, taking into account the molecular weight of hexadecapeptide (XIII), was only 0.1%, 500 ng of which antigen was required to displace half of the label. When the C-terminal glycine residue of octapeptide (X) was implicated in a peptide linkage with only a single lysine residue, as in the case of the trypsin-digested hexadecapeptide (XIII), the level of recognition was still only 0.4%. Only after further carboxypeptidase B digestion was the level of recognition restored to 80% of that of octapeptide (X); the small loss of potency in cross-reactivity was certainly due to the incomplete digestion of hexadecapeptide (XIII) by the proteases. The very low levels of cross-reactivity between trypsin-and carboxypeptidase B-digested PPD and Aoyama/B or BCG extracts and octapeptide (X) in the radioimmunoassays are, therefore, to some degree, underestimated, as the action of the proteases on these substrates was probably not complete. The observed cross-reaction of trypsin-and carboxypeptidase B-digested PPD with octapeptide (X) is, however, of the same order of magnitude as the one observed in our previous study (9) when the 125I-labeled heptapeptide (70 to 76; Fig. 1 ) and an anti-heptapeptide antiserum were used in the radioimmunoassays. The similarity of these results seems, therefore, to indicate that the sequences given by Kuwabara (6) for the heptapeptide (70 to 76; Fig. 1 ) and for octapeptide (X) (61 to 68; Fig. 1 ) are correct, as is the structure of the synthetic peptides, since the ratio of these peptides in PPD, even in the form of larger protein fragments, can be expected to be 1:1. These considerations lead us to believe that the heptapeptide (70 to 76; Fig. 1 ) does not represent an antigenic determinant responsible for the delayed-type allergic tuberculin reaction, as we previously reported (9) , and that the reason for the discrepancy between our results and those reported by Kuwabara does not reside in an incorrect sequence of the heptapeptide. .) The exceedingly low levels of cross-reactivity observed in the radioimmunoassays with the trypsin-and carboxypeptidase B-digested extracts of Aoyama/B and BCG do not permit much interpretation as the reported amounts of antigen added in the radioimmunoassays (Fig. 3) are only extrapolated values from inhibition curves. However, a definite trend emerges from these results, showing better cross-reactivity in M. tuberculosis extracts, whether PPD or Aoyama/B, than in the M. bovis BCG extract. This trend might only reflect the different concentrations of the same peptide (61 to 68; Fig. 1 ) in these extracts, but it might also show that a peptide of a different structure than that of octapeptide (X) is present in the M. bovis extract, as is indicated by the tuberculin activity results. If the latter is true, the difference of sequence should reside in the C-terminal portion of octapeptide (X).
We are now investigating the apparent ability of our synthetic peptides to distinguish, in skin tests, animals sensitized with different species of mycobacteria and the possibilities of increasing the low specific tuberculinic activity of these peptides. 
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